Tag Archives: COVID-19

OPERATION WARP SPEEDD TO ACCELERATE VACCINE DEVELOPMENT

In the United States, Operation Warp Speed (OWS) is a collaboration of several US government departments, including Health and Human Services, and the private sector. Through it, the National Institutes of Health (NIH) has entered into collaboration with 18 bio pharmaceutical companies to accelerate development of drugs and vaccines to …

Read More »

INDIA’s COVID-19 VACCINE DEVELOPMENT

Director General Balram Bhargava of the Indian Council of Medical Research (ICMR) has announced that Phase 2 clinical trials of two indigenously developed COVID-19 vaccines have been almost completed. India has two indigenous vaccine candidates—ZyCOV-D by Zydus Cadila and Covaxin by Bharat Biotech. He said that while final trials normally …

Read More »

Australia’s Vaccination Plans

Backtracking on his earlier suggestion to make COVID-19 vaccination mandatory for all, the Australian prime minister has clarified, “There are no compulsory vaccines in Australia,” and that there will be “no compulsory vaccine, but there will be a lot of encouragement and measures to get as high a rate of …

Read More »

China’s Vaccine for COVID-19

The Wuhan Institute of Biological Products has announced that its COVID-19 vaccine will be commercially available by the end of December, 2020. Chinese vaccine manufacturer Sinopharm CNBG has begun conducting Phase 3 clinical trials of the vaccine in thousands of human volunteers, after it was found to provoke strong antibody …

Read More »

Russia is the Frontrunner with Sputnik V

President Vladimir Putin has announced that Russia’s health ministry has granted regulatory approval for Phase 3 clinical trials of the Sputnik V vaccine, which will begin very shortly, with tens of thousands of people in the Moscow region being vaccinated to gauge its efficacy and safety. In doing so, Russia …

Read More »
Sahifa Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.